Physician profile
Michael T Casey
NPI 1134109804
$2,877.10
in general payments reported to CMS, 2019-2025
19 companies · $1,616 in 2025
The $1,616 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $89.69 · 2021: $15.04 · 2022: $69.87 · 2023: $82.01 · 2024: $818 · 2025: $1,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,356 · Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,355.76 |
| Food and Beverage | $1,160.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,054.90 | 2025 | |
| Smoky Mountain Surgical LLC | $946.42 | 2024-2025 | |
| Boston Scientific Corporation | $180.24 | 2024-2025 | Apollo Esg Nxt System, Axios, General - Biliary Devices |
| Stryker Corporation | $170.15 | 2024 | 1788 |
| Amgen INC. | $80.07 | 2019-2020 | |
| Abbott Laboratories | $65.25 | 2022-2025 | Proclaim, Eterna |
| Ferring Pharmaceuticals INC. | $60.53 | 2020-2023 | Euflexxa |
| Alpha Orthopedic Systems | $39.26 | 2020 | |
| Pacira Therapeutics, INC. | $38.10 | 2019 | |
| Vericel Corporation | $37.78 | 2022-2023 | Maci |
| Zimmer Biomet Holdings, INC. | $31.80 | 2019 | |
| Endo Pharmaceuticals INC. | $28.08 | 2019-2023 | Xiaflex |
| Genentech USA, INC. | $25.86 | 2025 | Vabysmo |
| Cumberland Pharmaceuticals, INC. | $25.85 | 2020 | |
| Radius Health, INC. | $23.03 | 2025 | Tymlos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.95 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.98 | 2025 | |
| Novo Nordisk INC | $15.04 | 2021 | |
| Pfizer INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.